Thoracic Aortic Three-Dimensional Geometry
- PMID: 40330437
- PMCID: PMC12052382
- DOI: 10.1159/000543613
Thoracic Aortic Three-Dimensional Geometry
Abstract
Introduction: Aortic structure impacts cardiovascular health through multiple mechanisms. Aortic structural degeneration occurs with aging, increasing left ventricular afterload and promoting increased arterial pulsatility and target organ damage. Despite the impact of aortic structure on cardiovascular health, three-dimensional (3D) aortic geometry has not been comprehensively characterized in large populations.
Methods: We segmented the complete thoracic aorta using a deep learning architecture and used morphological image operations to extract multiple aortic geometric phenotypes (AGPs, including diameter, length, curvature, and tortuosity) across various subsegments of the thoracic aorta. We deployed our segmentation approach on imaging scans from 54,241 participants in the UK Biobank and 8,456 participants in the Penn Medicine Biobank.
Conclusion: Our method provides a fully automated approach toward quantifying the three-dimensional structural parameters of the aorta. This approach expands the available phenotypes in two large representative biobanks and will allow large-scale studies to elucidate the biology and clinical consequences of aortic degeneration related to aging and disease states.
Keywords: 3D aortic structure; Automated segmentation; Deep learning; Thoracic aorta.
© 2025 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
Dr. Chirinos has recently consulted for Bayer, Fukuda-Denshi, Bristol-Myers Squibb, Biohaven Pharmaceuticals, Johnson & Johnson, Edwards Life Sciences, Merck, and NGM Biopharmaceuticals. He received University of Pennsylvania research grants from National Institutes of Health, Fukuda-Denshi, Bristol-Myers Squibb, Microsoft and Abbott. He is named as an inventor in a University of Pennsylvania patent for the use of inorganic nitrates/nitrites for the treatment of Heart Failure and Preserved Ejection Fraction and for the use of biomarkers in heart failure with preserved ejection fraction. He has received payments for editorial roles from the American Heart Association, the American College of Cardiology, Elsevier and Wiley, and payments for academic roles from the University of Texas, Boston University, and Virginia Commonwealth University. He has received research device loans from AtCor Medical, Fukuda-Denshi, Unex, Uscom, NDD Medical Technologies, Microsoft, and MicroVision Medical. The remaining authors have nothing to disclose.
Update of
-
Thoracic Aortic Three-Dimensional Geometry.bioRxiv [Preprint]. 2024 Oct 31:2024.05.09.593413. doi: 10.1101/2024.05.09.593413. bioRxiv. 2024. Update in: Pulse (Basel). 2025 Jan 27;13(1):72-79. doi: 10.1159/000543613. PMID: 38798566 Free PMC article. Updated. Preprint.
References
-
- Adriaans BP, Heuts S, Gerretsen S, Cheriex EC, Vos R, Natour E, et al. . Aortic elongation part I: the normal aortic ageing process. Heart. 2018;104(21):1772–7. - PubMed
-
- Heuts S, Adriaans BP, Gerretsen S, Natour E, Vos R, Cheriex EC, et al. . Aortic elongation part II: the risk of acute type A aortic dissection. Heart. 2018;104(21):1778–82. - PubMed
-
- Rylski B, Desjardins B, Moser W, Bavaria JE, Milewski RK. Gender-related changes in aortic geometry throughout life. Eur J Cardio Thorac Surg. 2014;45(5):805–11. - PubMed
LinkOut - more resources
Full Text Sources
